首页> 外国专利> Set of markers for the detection of hepatic metastases of colorectal cancer and kit for detecting liver metastases of colorectal cancer.

Set of markers for the detection of hepatic metastases of colorectal cancer and kit for detecting liver metastases of colorectal cancer.

机译:一套用于检测大肠癌肝转移的标记物和一套用于检测大肠癌肝转移的试剂盒。

摘要

Set of markers for the detection of hepatic metastases of colorectal cancer and kit for detecting liver metastases of colorectal cancer. # The present invention relates to a set of markers for the detection of hepatic metastases in patients with colorectal cancer. This assembly, including the marker DCC (18q21.3) known in the literature, further comprising the ASAPl ​​(8q24.1-q24.2), ZMYM2 (13qll-q12), MYBL2 (20q13.1), TDP52L2 (markers 20qtel) and SMAD4 (18q21.1). Optionally also includes MSRI (8p22), TNKS (8p23.1), CYP24A1 (20q13) and / or AURKA (20q13.2-13.3) markers. This set of markers was chosen from results obtained by various methods as the CGHa low and high density, Q-PCR and FISH, where the results of Q-PCR were analyzed facing the absolute and relative method of this analysis. a kit for detection of liver metastasis in colorectal cancer patients comprising this set of markers is also presented.
机译:一套用于检测大肠癌肝转移的标记物和一套用于检测大肠癌肝转移的试剂盒。本发明涉及用于检测结肠直肠癌患者中肝转移的一组标记物。该程序集包括文献中已知的标记DCC(18q21.3),进一步包含ASAPl​​(8q24.1-q24.2),ZMYM2(13qll-q12),MYBL2(20q13.1),TDP52L2(标记20qtel)和SMAD4(18q21.1)。可选地,还包括MSRI(8p22),TNKS(8p23.1),CYP24A1(20q13)和/或AURKA(20q13.2-13.3)标记。从通过各种方法(如CGHa低密度和高密度),Q-PCR和FISH获得的结果中选择这组标记,其中针对该分析的绝对和相对方法对Q-PCR的结果进行分析。还提供了一种用于检测大肠癌患者肝转移的试剂盒,其中包括该组标记。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号